Compare ALM & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALM | HIMS |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Nursing Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.4B |
| IPO Year | 2016 | 2019 |
| Metric | ALM | HIMS |
|---|---|---|
| Price | $18.04 | $28.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | $22.33 | ★ $30.46 |
| AVG Volume (30 Days) | 6.6M | ★ 12.2M |
| Earning Date | 05-20-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,347,637,000.00 |
| Revenue This Year | $817.94 | $19.82 |
| Revenue Next Year | $158.05 | $19.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $3.98 | $13.74 |
| 52 Week High | $24.41 | $65.30 |
| Indicator | ALM | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 46.96 |
| Support Level | $12.47 | $27.67 |
| Resistance Level | $19.35 | $31.12 |
| Average True Range (ATR) | 1.09 | 2.09 |
| MACD | 0.43 | 0.11 |
| Stochastic Oscillator | 87.64 | 29.96 |
Almonty Industries Inc is engaged in the development of the Sangdong Mine in South Korea, and the Company is currently mining, processing, and shipping tungsten concentrate from the Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal (Panasqueira Mine). Additionally, the Company is evaluating its molybdenum project with inferred mineral resources on a separate property adjacent to the tungsten orebody at the Sangdong Mine, its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora (Valtreixal Mine), and the newly-acquired Gentung Browns Lake tungsten project located in Montana, USA (Gentung-Browns Lake Project). The company has two geographical locations: the Iberian Peninsula (Spain and Portugal) and the Republic of Korea.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.